AstraZeneca PLC.
ORGANIZATION
RELATED TO.
Delaware River
PLACE
American Cancer Society
ORGANIZATION
Wilmington, DE
PLACE
Arthritis
DISEASE
American Red Cross
ORGANIZATION
Autism
DISEASE
India's patents appeal board has dismissed British drugmaker AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fighting drug, in the latest blow for Big Pharma in the country.
The Indian patents office in 2007 refused patent protection to AstraZeneca's quinazoline molecule, citing lack of invention. The Intellectual Property Appellate Board (IPAB) on Monday upheld the refusal.
The decision is a setback for struggling AstraZeneca, which is battling to turn itself around as key drugs lose patent protection.
FIRSTPOST. ARTICLES
View all
Sensex falters; summer drought sparks worries
Aug-03, 2012India drugs inquiry could prompt new U.S. scrutiny
May-11, 2012
FROM THE WEB.
Is AstraZeneca Gearing Up for a Shopping Spree?
May-15,2013